diclofenac and latanoprost

diclofenac has been researched along with latanoprost in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (14.29)	18.2507
2000's	3 (42.86)	29.6817
2010's	3 (42.86)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Ichihashi, S; Maekubo, K; Miyake, K; Miyake, S; Ota, I	1
Antinozzi, PP; Caccavale, A; Costagliola, C; Cotticelli, L; Parmeggiani, F; Sebastiani, A	1
Hadden, OB; McGhee, CN; Niederer, RL; Wheeldon, CE	1
Bek, T; Tilma, KK	1
Del Soldato, P; Giustarini, D; Rossi, R; Santus, G; Sparatore, A	1
Allbaugh, R; Ben-Shlomo, G; Griggs, A; Strong, T; Tofflemire, K; Whitley, EM; Whitley, RD	1

Reviews

1 review(s) available for diclofenac and latanoprost

Article	Year
Therapeutic potential of new hydrogen sulfide-releasing hybrids. Expert review of clinical pharmacology, 2011, Volume: 4, Issue:1 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Diclofenac; Humans; Hydrogen Sulfide; Inflammation; Latanoprost; Levodopa; Prodrugs; Prostaglandins F, Synthetic	2011

Trials

4 trial(s) available for diclofenac and latanoprost

Article	Year
Latanoprost accelerates disruption of the blood-aqueous barrier and the incidence of angiographic cystoid macular edema in early postoperative pseudophakias. Archives of ophthalmology (Chicago, Ill. : 1960), 1999, Volume: 117, Issue:1 Topics: Aged; Blood-Aqueous Barrier; Cataract Extraction; Diclofenac; Double-Blind Method; Female; Fluorescein Angiography; Fluorometholone; Glaucoma, Open-Angle; Humans; Incidence; Intraocular Pressure; Latanoprost; Lens Implantation, Intraocular; Macular Edema; Male; Ocular Hypertension; Ophthalmic Solutions; Prostaglandins F, Synthetic; Pseudophakia	1999
The influence of diclofenac ophthalmic solution on the intraocular pressure-lowering effect of topical 0.5% timolol and 0.005% latanoprost in primary open-angle glaucoma patients. Experimental eye research, 2005, Volume: 81, Issue:5 Topics: Administration, Topical; Adrenergic beta-Antagonists; Aged; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Diclofenac; Drug Synergism; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ophthalmic Solutions; Prostaglandins F, Synthetic; Sample Size; Timolol; Tonometry, Ocular	2005
Topical treatment for 1 week with latanoprost but not diclofenac reduces the diameter of dilated retinal arterioles in patients with type 1 diabetes mellitus and mild retinopathy. Acta ophthalmologica, 2012, Volume: 90, Issue:8 Topics: Administration, Topical; Adult; Antihypertensive Agents; Arterioles; Blood Glucose; Blood Pressure; Cross-Over Studies; Cyclooxygenase Inhibitors; Diabetes Mellitus, Type 1; Diabetic Retinopathy; Diclofenac; Double-Blind Method; Female; Hemostasis; Humans; Intraocular Pressure; Latanoprost; Male; Prostaglandins F, Synthetic; Retinal Artery; Vasodilation; Visual Acuity	2012
Effect of topical ophthalmic latanoprost 0.005% solution alone and in combination with diclofenac 0.1% solution in healthy horses: a pilot study. Veterinary ophthalmology, 2017, Volume: 20, Issue:5 Topics: Administration, Topical; Animals; Antihypertensive Agents; Diclofenac; Double-Blind Method; Drug Therapy, Combination; Horses; Intraocular Pressure; Latanoprost; Ophthalmic Solutions; Pilot Projects; Prostaglandins F, Synthetic; Pupil	2017

Other Studies

2 other study(ies) available for diclofenac and latanoprost

Article	Year
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Presumed late diffuse lamellar keratitis progressing to interface fluid syndrome. Journal of cataract and refractive surgery, 2008, Volume: 34, Issue:2 Topics: Adult; Body Fluids; Corneal Stroma; Diclofenac; Drug Therapy, Combination; Humans; Intraocular Pressure; Keratitis; Keratomileusis, Laser In Situ; Latanoprost; Male; Microscopy, Confocal; Ophthalmic Solutions; Prostaglandins F, Synthetic; Surgical Flaps; Syndrome; Visual Acuity	2008

Article

Year

Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.

Current drug discovery technologies, 2004, Volume: 1, Issue:4

Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004

Presumed late diffuse lamellar keratitis progressing to interface fluid syndrome.

Journal of cataract and refractive surgery, 2008, Volume: 34, Issue:2

Topics: Adult; Body Fluids; Corneal Stroma; Diclofenac; Drug Therapy, Combination; Humans; Intraocular Pressure; Keratitis; Keratomileusis, Laser In Situ; Latanoprost; Male; Microscopy, Confocal; Ophthalmic Solutions; Prostaglandins F, Synthetic; Surgical Flaps; Syndrome; Visual Acuity

2008